Afatinib is effective in lung adenocarcinoma with an epidermal growth factor receptor exon 19 deletion-insertion (E746_A750delinsIP) detected by comprehensive genomic profiling: A case report
Afatinib is effective in lung adenocarcinoma with an epidermal growth factor receptor exon 19 deletion-insertion (E746_A750delinsIP) detected by comprehensive genomic profiling: A case report. // Respiratory Medicine Case Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2213007126001759?dgcid=rss_sd_all
Afatinib is effective in lung adenocarcinoma with an epidermal growth factor receptor exon 19 deletion-insertion (E746_A750delinsIP) detected by comprehensive genomic profiling: A case report. Respiratory Medicine Case Reports. https://www.sciencedirect.com/science/article/pii/S2213007126001759?dgcid=rss_sd_all
“Afatinib is effective in lung adenocarcinoma with an epidermal growth factor receptor exon 19 deletion-insertion (E746_A750delinsIP) detected by comprehensive genomic profiling: A case report.” Respiratory Medicine Case Reports.
@article{article31931,
title = {Afatinib is effective in lung adenocarcinoma with an epidermal growth factor receptor exon 19 deletion-insertion (E746\_A750delinsIP) detected by comprehensive genomic profiling: A case report},
journal = {Respiratory Medicine Case Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2213007126001759?dgcid=rss_sd_all}
}